ArticleCancer research and treatment2026

Efficacy and Safety of Lenvatinib Plus Everolimus in Metastatic Renal Cell Carcinoma after Immune Checkpoint and VEGFR Tyrosine Kinase Inhibitors Treatment.

So Heun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.